Glycogen Synthase Kinase 3 β Hepatocyte Deletion Attenuates Ferroptosis and Metabolic Dysfunction-associated Steatohepatitis in Mice
Khaled Warasnhe(Mayo Clinic), Samar H. Ibrahim(Mayo Clinic), Hyun Se Kim Lee(Mayo Clinic in Arizona), Stella Victorelli(Mayo Clinic in Florida), Lucía Valenzuela-Pérez(Mayo Clinic in Arizona), Peyton Classon(Mayo Clinic), Adebowale O. Bamidele(Mayo Clinic), Akitoshi Sano(Tohoku University), Petra Hirsova(Mayo Clinic), Qianqian Guo(Jilin University), Nantawat Satthawiwat(Chulalongkorn University), Davide Povero(University of California San Diego), Xin Dai(Tianjin Medical University General Hospital), Chady Meroueh(Mayo Clinic)
Cited by 8
Related Papers
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
|EBioMedicine|2019|1.3k
Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
|Cell Metabolism|2019|547
Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence
|The EMBO Journal|2019|513
Telomeres and Cell Senescence - Size Matters Not
|EBioMedicine|2017|412